18 employees
Muvon Therapeutics is a biotech company developing autologous cell therapies to restore skeletal muscle.
2020
MUVON Therapeutics AG raised undisclosed on May 31, 2021
Investors: Lichtsteiner Foundation, Wyss Translational Center Zurich and University of Zurich